Impact of cardiovascular illness on hospitalization costs in patients with rheumatoid arthritis.
Keywords:
rheumatoid arthritis, comorbidity, cardiovascular disease, directs costs, hospitalization, infection, mortality
Abstract
The causes of admission and the distribution of direct medical costs were examined to establish the clinical predictors of high hospitalization costs in patients with rheumatoid arthritis. This retrospective study included all rheumatoid arthritis patients who were hospitalized in the Clínica Universitaria Bolivariana in Medellín, Colombia, between January 1999 and June 2003. Data were obtained from the medical records and from the hospital statistical section using a cost-analysis spreadsheet. A total of 41 patients were hospitalized 62 times (0.34 hospitalization per patient per year). Disease activity was the most important cause of admission (60%), followed by surgery (18%), and infection (10%). In 30 (48%) hospitalizations, at least one comorbidity was recorded, with cardiovascular disease being the most frequent (32%). The mean length of stay per patient was 5+/-6 days. The mean total cost was 1,277 US dollars, and the mean cost per day of hospitalization was 235 US dollars. Medications represented 54% of the total cost, whereas that representing medical care was only 3%. Variance analysis disclosed cardiovascular disease as the most important determinant of high costs (p<0.01). In conclusion, the direct costs for inpatients with rheumatoid arthritis were considerable, and arose mainly from organic complications. Prevention and treatment of cardiovascular disease are indispensable not only to reduce the economic burden of rheumatoid arthitis, but also to diminish the risk of mortality. These data assist in the estimation of health care resources and in the selection of public health policies for the improvement of patient outcomes.Downloads
Download data is not yet available.
How to Cite
1.
Pineda-Tamayo R, Arcila G, Restrepo P, Anaya JM. Impact of cardiovascular illness on hospitalization costs in patients with rheumatoid arthritis. Biomed. [Internet]. 2004 Dec. 1 [cited 2024 Aug. 18];24(4):366-74. Available from: https://revistabiomedica.org/index.php/biomedica/article/view/1286
Some similar items:
- Martha C. Domínguez, Mercedes Salcedo, Felipe García, Serological and virological evaluation of human T-lymphotropic virus type 1 infection in family groups from Tumaco, Colombia , Biomedica: Vol. 35 No. 3 (2015)
Published
2004-12-01
Issue
Section
Original articles
Article metrics | |
---|---|
Abstract views | |
Galley vies | |
PDF Views | |
HTML views | |
Other views |